Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CRBP |
---|---|---|
09:32 ET | 10651 | 17.39 |
09:33 ET | 8347 | 17.5712 |
09:35 ET | 2541 | 17.445 |
09:37 ET | 500 | 17.605 |
09:42 ET | 694 | 17.42 |
09:44 ET | 100 | 17.3301 |
09:46 ET | 828 | 17.5218 |
09:48 ET | 1229 | 17.43 |
09:50 ET | 700 | 17.4682 |
09:51 ET | 3008 | 17.68 |
09:53 ET | 400 | 17.615 |
09:55 ET | 100 | 17.68 |
09:57 ET | 271 | 17.686 |
10:00 ET | 1828 | 17.84 |
10:02 ET | 5424 | 17.789 |
10:04 ET | 3350 | 17.92 |
10:06 ET | 592 | 17.87 |
10:08 ET | 750 | 17.841 |
10:09 ET | 1690 | 17.86 |
10:11 ET | 1537 | 17.84 |
10:13 ET | 2719 | 17.7626 |
10:15 ET | 5017 | 17.83 |
10:18 ET | 1080 | 17.8879 |
10:20 ET | 937 | 17.9 |
10:22 ET | 500 | 17.87 |
10:24 ET | 2375 | 17.87 |
10:26 ET | 489 | 17.78 |
10:27 ET | 2553 | 17.8151 |
10:31 ET | 100 | 17.885 |
10:33 ET | 1700 | 18.0017 |
10:36 ET | 4725 | 18.05 |
10:38 ET | 4156 | 18 |
10:40 ET | 600 | 17.97 |
10:42 ET | 769 | 17.95 |
10:44 ET | 780 | 17.95 |
10:45 ET | 100 | 17.955 |
10:47 ET | 600 | 17.99 |
10:49 ET | 300 | 17.975 |
10:51 ET | 1100 | 17.9601 |
10:54 ET | 300 | 18.055 |
10:56 ET | 600 | 18.03 |
10:58 ET | 604 | 18.0348 |
11:00 ET | 2721 | 18.216 |
11:02 ET | 3067 | 18.2175 |
11:03 ET | 1461 | 18.2 |
11:05 ET | 3075 | 18.24 |
11:07 ET | 4352 | 18.36 |
11:09 ET | 971 | 18.42 |
11:12 ET | 4891 | 18.45 |
11:14 ET | 679 | 18.415 |
11:16 ET | 2305 | 18.35 |
11:18 ET | 1500 | 18.39 |
11:20 ET | 3167 | 18.27 |
11:21 ET | 308 | 18.265 |
11:23 ET | 161 | 18.224 |
11:25 ET | 2051 | 18.26 |
11:30 ET | 100 | 18.26 |
11:32 ET | 676 | 18.2 |
11:34 ET | 545 | 18.17 |
11:36 ET | 250 | 18.075 |
11:38 ET | 3036 | 18.3 |
11:39 ET | 1300 | 18.29 |
11:41 ET | 2874 | 18.42 |
11:43 ET | 1019 | 18.45 |
11:45 ET | 700 | 18.45 |
11:48 ET | 4996 | 18.4002 |
11:50 ET | 8341 | 18.5201 |
11:52 ET | 3600 | 18.65 |
11:54 ET | 8990 | 18.75 |
11:56 ET | 1900 | 18.705 |
11:57 ET | 1440 | 18.72 |
11:59 ET | 1020 | 18.67 |
12:01 ET | 100 | 18.76 |
12:03 ET | 242 | 18.6714 |
12:06 ET | 200 | 18.75 |
12:08 ET | 800 | 18.695 |
12:12 ET | 2339 | 18.77 |
12:14 ET | 100 | 18.72 |
12:15 ET | 5980 | 18.875 |
12:17 ET | 2308 | 18.94 |
12:19 ET | 1328 | 18.865 |
12:21 ET | 971 | 18.9 |
12:24 ET | 4317 | 18.999 |
12:26 ET | 1076 | 19.19 |
12:28 ET | 5734 | 19.31 |
12:30 ET | 4880 | 19.13 |
12:32 ET | 1396 | 19.01 |
12:33 ET | 1759 | 18.87 |
12:35 ET | 1608 | 18.9094 |
12:37 ET | 575 | 18.87 |
12:39 ET | 8564 | 19 |
12:42 ET | 4470 | 18.75 |
12:44 ET | 600 | 18.835 |
12:46 ET | 600 | 18.97 |
12:48 ET | 100 | 18.97 |
12:50 ET | 4869 | 19 |
12:51 ET | 5466 | 19.03 |
12:53 ET | 9130 | 19 |
12:55 ET | 766 | 18.93 |
12:57 ET | 1936 | 18.91 |
01:00 ET | 1475 | 18.92 |
01:04 ET | 2692 | 18.745 |
01:06 ET | 1000 | 18.745 |
01:08 ET | 1520 | 18.835 |
01:09 ET | 100 | 18.81 |
01:11 ET | 4376 | 18.69 |
01:13 ET | 100 | 18.69 |
01:15 ET | 500 | 18.7425 |
01:18 ET | 1327 | 18.76 |
01:20 ET | 664 | 18.82 |
01:22 ET | 100 | 18.87 |
01:24 ET | 1503 | 18.715 |
01:26 ET | 1014 | 18.675 |
01:27 ET | 899 | 18.63 |
01:29 ET | 200 | 18.63 |
01:31 ET | 1440 | 18.63 |
01:33 ET | 2500 | 18.575 |
01:36 ET | 939 | 18.565 |
01:38 ET | 300 | 18.58 |
01:40 ET | 415 | 18.595 |
01:42 ET | 100 | 18.635 |
01:44 ET | 871 | 18.64 |
01:45 ET | 300 | 18.67 |
01:47 ET | 2490 | 18.61 |
01:49 ET | 250 | 18.6 |
01:54 ET | 1597 | 18.635 |
01:56 ET | 100 | 18.655 |
01:58 ET | 2700 | 18.625 |
02:00 ET | 1879 | 18.58 |
02:03 ET | 1295 | 18.54 |
02:05 ET | 100 | 18.545 |
02:07 ET | 400 | 18.56 |
02:09 ET | 3872 | 18.44 |
02:12 ET | 195 | 18.475 |
02:14 ET | 100 | 18.53 |
02:16 ET | 202 | 18.486 |
02:18 ET | 987 | 18.505 |
02:20 ET | 250 | 18.5131 |
02:21 ET | 200 | 18.515 |
02:23 ET | 423 | 18.51 |
02:25 ET | 200 | 18.52 |
02:27 ET | 765 | 18.51 |
02:30 ET | 1600 | 18.53 |
02:32 ET | 5116 | 18.5064 |
02:34 ET | 300 | 18.55 |
02:36 ET | 600 | 18.5545 |
02:38 ET | 600 | 18.44 |
02:41 ET | 1424 | 18.25 |
02:43 ET | 1150 | 18.3 |
02:45 ET | 2107 | 18.36 |
02:48 ET | 200 | 18.41 |
02:50 ET | 400 | 18.32 |
02:52 ET | 150 | 18.3399 |
02:54 ET | 271 | 18.3 |
02:56 ET | 300 | 18.315 |
02:57 ET | 2038 | 18.38 |
02:59 ET | 250 | 18.37 |
03:01 ET | 200 | 18.39 |
03:03 ET | 1800 | 18.43 |
03:06 ET | 200 | 18.5 |
03:08 ET | 200 | 18.48 |
03:10 ET | 100 | 18.48 |
03:12 ET | 3400 | 18.37 |
03:14 ET | 2500 | 18.52 |
03:15 ET | 1805 | 18.5176 |
03:17 ET | 900 | 18.49 |
03:19 ET | 200 | 18.51 |
03:21 ET | 800 | 18.47 |
03:24 ET | 600 | 18.42 |
03:26 ET | 2918 | 18.45 |
03:28 ET | 100 | 18.425 |
03:30 ET | 600 | 18.45 |
03:32 ET | 1042 | 18.45 |
03:33 ET | 200 | 18.4 |
03:35 ET | 6876 | 18.46 |
03:37 ET | 300 | 18.44 |
03:39 ET | 1654 | 18.455 |
03:42 ET | 1589 | 18.49 |
03:44 ET | 3342 | 18.54 |
03:46 ET | 2457 | 18.525 |
03:48 ET | 1700 | 18.5499 |
03:50 ET | 5629 | 18.54 |
03:51 ET | 2100 | 18.44 |
03:53 ET | 3104 | 18.46 |
03:55 ET | 4063 | 18.435 |
03:57 ET | 3814 | 18.315 |
04:00 ET | 61953 | 18.31 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Corbus Pharmaceuticals Holdings Inc | 203.8M | -3.1x | --- |
Kodiak Sciences Inc | 202.0M | -1.0x | --- |
Gossamer Bio Inc | 197.7M | -2.2x | --- |
Kyverna Therapeutics Inc | 211.0M | 0.0x | --- |
PepGen Inc | 211.2M | -2.1x | --- |
CAMP4 Therapeutics Corp | 196.0M | -3.2x | --- |
Corbus Pharmaceuticals Holdings, Inc. is a precision oncology company with a diversified portfolio. The Company's pipeline is comprised of two experimental drugs targeting solid tumors: CRB-701, which is an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload and CRB-601, which is an anti-integrin monoclonal antibody that blocks the activation of TGFβ expressed on cancer cells. Its pipeline also includes CRB-913, which is a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has in-licensed the intellectual property for CRB-601 from Dr. Stephen Nishimura's laboratory at the University of California, San Francisco. The Company does not own or operate manufacturing facilities and relies on third-party contract manufacturing organizations or licensing partners to supply it with drugs for pre-clinical and clinical studies and commercial activities.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $203.8M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 12.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.59 |
EPS | $-5.82 |
Book Value | $-1.56 |
P/E Ratio | -3.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.